Open-label V565 Target Engagement Study

Summary

The purpose of the study is to confirm that V565 enters inflamed tissue, binds to TNF and reduces inflammation after oral dosing to patients with IBD.

Timeline

Start

2017-05-23

Primary completion

2017-10-24

Completion

2017-10-24

Drugs

Indications